Clinical Trial Liability Insurance. Within thirty (30) days prior to the initiation of human clinical trials with respect to Licensed Product(s), Company will provide to University certificates evidencing the existence and amount of clinical trials liability insurance. Company will issue irrevocable instructions to its insurance agent and to the issuing insurance company to notify University of any discontinuance or lapse of such insurance not less than thirty (30) days prior to the time that any such discontinuance is due to become effective. Company will provide University a copy of such instructions upon their transmittal to the insurance agent and issuing insurance company. Company will further provide University, at least annually, proof of continued coverage.
Clinical Trial Liability Insurance. Within thirty (30) days prior to the initiation of human clinical trials with respect to Licensed Product(s), Adaptimmune shall provide to Universal copies of certificates evidencing the existence and amount of clinical trials liability insurance following request from Universal for copies of such certificates.
Clinical Trial Liability Insurance. On initiation of human clinical trials with respect to Licensed Product(s), Adaptimmune shall provide to Universal certificates evidencing the existence and amount of clinical trials liability insurance, following receipt of request from Universal. Adaptimmune shall further provide Universal, at least annually, proof of continued coverage to the extent such clinical trials are continuing and following receipt of request from Universal.
Clinical Trial Liability Insurance. Within [***] days prior to the initiation of human clinical trials with respect to Licensed Product(s), Company will provide to University certificates evidencing the existence and amount of clinical trials liability insurance. Company will issue irrevocable instructions to its insurance agent and to the issuing insurance company to notify University of any discontinuance or lapse of such insurance not less than [***] days prior to the time that any such discontinuance is due to become effective. Company will provide University a copy of such instructions upon t heir transmittal to the insurance agent and issuing insurance company. Company will further provide University [***] proof of continued coverage.
Clinical Trial Liability Insurance. Within [***] days prior to the initiation of human clinical trials with respect to Licensed Product(s), Company will provide to University certificates Icosavax Inc. / University of Washington Non-Exclusive License Agreement UW CoMotion Ref. [***] Page 15 of 33 |US-DOCS\130755718.2|| evidencing the existence and amount of clinical trials liability insurance. Company will issue irrevocable instructions to its insurance agent and to the issuing insurance company to notify University of any discontinuance or lapse of such insurance not less than [***] days prior to the time that any such discontinuance is due to become effective. Company will provide University a copy of such instructions upon their transmittal to the insurance agent and issuing insurance company. Company will further provide University, at least annually, proof of continued coverage.
Clinical Trial Liability Insurance. Within thirty (30) days prior to the initiation of human clinical trials with respect to Licensed Product(s), Company will provide to University certificates evidencing the existence and amount of clinical trials liability insurance. Company will issue irrevocable instructions to its insurance agent and to the issuing insurance company to notify University of any discontinuance or lapse of such insurance not less than thirty (30) days prior to the time that any such discontinuance is due to become effective. Company will provide University a copy of such instructions upon their transmittal to the insurance agent and issuing insurance company. Company will further provide University, at least annually, proof of continued coverage. Akoya Biosciences, Inc. / University of Washington Exclusive License Agreement UW CoMotion Ref. 43158A Page 13 of 23
Clinical Trial Liability Insurance. Within thirty (30) days prior to the initiation of human clinical trials with respect to Licensed Product(s), Development Partner will provide to UW certificates evidencing the existence and amount of clinical trials liability insurance. Development Partner will issue irrevocable instructions to its insurance agent and to the issuing insurance company to notify UW of any discontinuance or lapse of such insurance not less than 30 days prior to the time that any such discontinuance is due to become effective. Development Partner will provide UW a copy of such instructions upon their transmittal to the insurance agent and issuing insurance company. Development Partner will further provide UW, at least annually, proof of continued coverage.
Clinical Trial Liability Insurance. Within thirty (30) days prior to the initiation of human clinical trials with respect to Licensed Product(s), Commercialization Partner will provide to UW certificates evidencing the existence and amount of clinical trials liability insurance. Commercialization Partner will issue irrevocable instructions to its insurance agent and to the issuing insurance company to notify UW of any discontinuance or lapse of such insurance not less than 30 days prior to the time that any such discontinuance is due to become effective. Commercialization Partner will provide UW a copy of such instructions upon their transmittal to the insurance agent and issuing insurance company. Commercialization Partner will further provide UW, at least annually, proof of continued coverage.
Clinical Trial Liability Insurance in full force and effect during the Initial Term and any Renewal Term, and for five (5) years following the expiration or termination of this Agreement or the conclusion of the last human clinical trial (whichever is later). The minimum limits shall be [XXXXXXXX]each claim and aggregate (or if in a foreign currency, in an amount equivalent to USD[XXXXXXXX]). The use of primary and excess limits and self-insured layers to achieve the total required limits is acceptable. If written on a “claims-made basis” the policy shall contain a retroactive date equal to the Effective Date or earlier. If the policy is terminated at any time following the expiration or termination of this Agreement then equivalent tail coverage shall be purchased such that the coverage shall remain in full force and effect for the time periods stated above. This policy shall apply to and shall be written on an “admitted” basis in all countries where trials shall be conducted. It shall provide a worldwide coverage territory and respond to claims made anywhere in the world. The policies shall be endorsed to include ISP’s affiliates and subsidiaries as “additional insureds”.
